Prevalence & Impact of COVID-19 in Systemic Sclerosis Patients and Assessment of the Demographic & Clinical Features in Cases Associated with Worse Prognosis: Results of a Single Centre Registry

BACKGROUND: Our knowledge of the COVID-19 infection impact on systemic sclerosis (SSc) is scarce. This study aimed to assess the prevalence of COVID-19 infection and to determine the predictive factors of worse outcomes and death in SSc patients. METHODS: In this cohort study all patients who attend...

Descripción completa

Detalles Bibliográficos
Autores principales: Poormoghim, Hadi, GaffariRad, Fatemeh, Rahmani, Shahrzad, Mohtasham, Negin, Almasi, Simin, Sobhani, Ali, Salimi-Beni, Maryam, Andalib, Elham, Naeini, Parsa Amiri, Jalali, Arash
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Mediterranean Journal of Rheumatology (MJR) 2023
Materias:
Original Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10466350/
https://www.ncbi.nlm.nih.gov/pubmed/37654631
http://dx.doi.org/10.31138/mjr.34.2.172

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10466350/
https://www.ncbi.nlm.nih.gov/pubmed/37654631
http://dx.doi.org/10.31138/mjr.34.2.172

Ejemplares similares